Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Trump’s Second Term Could Turn LDT Regulation on its Head
Trump’s Second Term Could Turn LDT Regulation on its Head
Trump’s Second Term Could Turn LDT Regulation on its Head
Submitted by
admin
on November 17, 2024 - 9:32pm
Source:
Medical Devices and Diagnostics Industry
News Tags:
LDTs
Medtech
devices
FDA
Donald Trump
Headline:
Trump’s Second Term Could Turn LDT Regulation on its Head
snippet:
Trump's new term could lead to the repeal of FDA's LDT rule, reverting it to previous regulations or alternative oversight.
FDA’s final rule treats LDTs as medical devices, imposing stricter requirements, and raising concerns in the lab industry.
The ACLA is challenging the FDA’s LDT rule, while the VALID Act proposes an alternative framework.
Do Not Allow Advertisers to Use My Personal information